Do baseline atrial electrocardiographic and infarction patterns predict new-onset atrial fibrillation after ST-elevation myocardial infarction? Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial

Abstract Background Atrial infarction reportedly occurs in 0.7% to 52% of ST-elevation myocardial infarctions (STEMIs), up to two thirds of whom develop atrial fibrillation and flutter (AF). Prospective validation of electrocardiographic atrial infarction patterns is lacking. Hence, in STEMI patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of electrocardiology 2010-07, Vol.43 (4), p.351-358
Hauptverfasser:	van Diepen, Sean, MD, Siha, Hany, MD, Fu, Yuling, MD, Westerhout, Cynthia M., PhD, Lopes, Renato D., MD, Granger, Christopher B., MD, Armstrong, Paul W., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Atrial fibrillation Atrial Fibrillation - diagnosis Atrial Fibrillation - mortality Atrial Fibrillation - prevention & control Atrial infarction Cardiovascular Comorbidity Electrocardiography - statistics & numerical data Female Humans Incidence Male Middle Aged Myocardial infarction Myocardial Infarction - diagnosis Myocardial Infarction - drug therapy Myocardial Infarction - mortality Risk Assessment - methods Risk Factors Single-Chain Antibodies - administration & dosage Survival Analysis Survival Rate Treatment Outcome United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!